CONTACT US  |  ACCOUNT LOGIN  
| | | |
  The VAP Lipid Panel
The VAP Test
Who Should
   Get A VAP?
Literature &
   Publications
Clinical
   Evidence
Research &
   Clinical Trials
Wellness Partners
FAQs
The VAP Lipid Panel

  • Is the first comprehensive lipid profile to comply with guidelines (NCEP/ATP III, AACE, and ADA/ACC)
    • Guidelines recommend a comprehensive approach to risk stratification1-3
  • Is the test of choice for accurate, global cardiometabolic risk stratification and management
    • Provides comprehensive lipid analysis
    • Simultaneously and accurately measures cholesterol concentrations of all 5 lipoprotein classes and their subclasses in a non-fasting patient4
  • Clarifies risk and drives a personalized treatment approach based on 3 categories of residual cardiometabolic risk
    • Cholesterol - Directly measures LDL and HDL, providing accurate results in a non-fasting patient. Also measures subclasses including apoB, which reflects atherogenic load.
    • Triglycerides - Identifies triglyceride-rich disorders, including non-HDL, even in patients with seemingly normal triglyceride levels.
    • Heredity - Identifies Lp(a), a hereditary marker of risk.

Learn More About the VAP Lipid Panel

 

 

References

  1. Jellinger PS, Dickey RA, Ganda OP, et al; AACE Lipid Guidelines Committee. AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis. Endocr Pract. 2000;6(2):162-213.
  2. Grundy SM, Cleeman JI, Merz CN, et al; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227-239.
  3. Brunzell JD, Davidson M, Furberg CD, et al; American Diabetes Association; American College of Cardiology Foundation. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care. 2008;31(4):811-822.
  4. Analytical performance of the cholesterol profi le measurement by Vertical Auto Profi le [VAP]: analysis of NCEP III guidelines lipid analytes. Atherotech Web site. http://www.atherotech.com/images/vapliterature/pdfs/vapaccuracywhitepaper_20110831.pdf. Published 2011. Accessed May 10, 2012.

 

 




"Using the detailed lipid profiles in the VAP Cholesterol Test, we can identify atherosclerosis risk that goes far beyond the capabilities of the standard lipid profile. A cholesterol test which identifies the complete lipid picture can complement lipid risk identification and targeted lipid treatment in our clinical practices."

- Michael E. Cobble, M.D. AAFP, FNLA, Board Certified Clinical Lipidologist (NLA), Certified HTN Specialist (ASH), Masters in Psychopharmacology, Director Private Practice Canyons Medical Center, Adjunct Faculty Univ. Utah School of Medicine
THE VAP CHOLESTEROL TEST  |  ATHEROTECH DIAGNOSTIC TESTS  |  OUR HEALTHY HEART  |  THE LIPID LIBRARY  |  ABOUT ATHEROTECH
© Copyright 2014. Atherotech. All rights reserved.